SCHEMBL6010047

SCHEMBL6010047

NC(=O)NC(=O)c1ccc2cc(O)ccc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F12 P00748 1/20 0.55
DEGS1 O15121 2/20 0.53
PLAU P00749 10/20 0.51
MEN1 O00255 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
KMT2A Q03164 1/20 0.50
CLK1 P49759 1/20 0.50
DYRK1A Q13627 1/20 0.50
DYRK1B Q9Y463 1/20 0.50
PLG P00747 6/20 0.46
KLKB1 P03952 5/20 0.46
PRSS1 P07477 5/20 0.46
F2 P00734 4/20 0.46
PLAT P00750 4/20 0.46
KLK1 P06870 1/20 0.46
LCK P06239 1/20 0.46
MPO P05164 1/20 0.41
CYP3A4 P08684 1/20 0.41
KDM5A P29375 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9731103 0.84 PLAU (0.58) DEGS1PLAUMEN1NPC1RAB9A
SCHEMBL1707304 0.81 GFER (0.64) F12DEGS1PLAUMEN1NPC1
SCHEMBL11880294 0.81 GFER (0.61) DEGS1MEN1KMT2AMPOCYP3A4
Hydrochloric Acid SCHEMBL5693969 0.80 GFER (0.62) F12DEGS1PLAUMEN1NPC1
SCHEMBL14880024 0.79 KDM4E (0.60) F12DEGS1MEN1NPC1RAB9A
SCHEMBL28707902 0.79 LCK (0.70) F12PLAUMEN1NPC1RAB9A
SCHEMBL1808865 0.79 LCK (0.70) F12PLAUMEN1NPC1RAB9A
SCHEMBL5434715 0.78 SCN2A (0.50) F12DEGS1PLAUMEN1NPC1
Terephthalamide SCHEMBL28563305 0.77 PARP10 (0.61) F12PLAUMEN1NPC1RAB9A
SCHEMBL20704988 0.76 PLAU (0.57) F12DEGS1PLAUMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100400506-C Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative UENO SEIYAKU OYO KENKYUJO KK (JP) 2008-07-09 CN claimed
US-7030261-B2 Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2006-04-18 US claimed
CN-1680302-A Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative UENO SEIYAKU OYO KENKYUJO KK (JP) 2005-10-12 CN claimed
US-20050192442-A1 Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO 2005-09-01 US claimed
EP-1564206-A1 Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2005-08-17 EP claimed
CN-100400506-C Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative UENO SEIYAKU OYO KENKYUJO KK (JP) 2008-07-09 CN disclosed
CN-100400506-C Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative UENO SEIYAKU OYO KENKYUJO KK (JP) 2008-07-09 CN disclosed
CN-100400506-C Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative UENO SEIYAKU OYO KENKYUJO KK (JP) 2008-07-09 CN disclosed
US-7030261-B2 Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2006-04-18 US disclosed
US-7030261-B2 Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2006-04-18 US disclosed
US-7030261-B2 Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2006-04-18 US disclosed
CN-1680302-A Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative UENO SEIYAKU OYO KENKYUJO KK (JP) 2005-10-12 CN disclosed
CN-1680302-A Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative UENO SEIYAKU OYO KENKYUJO KK (JP) 2005-10-12 CN disclosed
CN-1680302-A Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative UENO SEIYAKU OYO KENKYUJO KK (JP) 2005-10-12 CN disclosed
US-20050192442-A1 Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO 2005-09-01 US disclosed
US-20050192442-A1 Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO 2005-09-01 US disclosed
US-20050192442-A1 Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO 2005-09-01 US disclosed
EP-1564206-A1 Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2005-08-17 EP disclosed
EP-1564206-A1 Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2005-08-17 EP disclosed
EP-1564206-A1 Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2005-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050192442-A1 Method for preparing 2-hydroxy-6-ureidocarbonyl naphthalene derivative HPD, UGDH, HAAO F12 4333/4885DEGS1 3889/4885PLAU 1386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.